Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake.
Using the N18-RE-105 neuroblastoma X retina cell line, we previously described Ca2(+)-dependent quisqualate-type glutamate toxicity caused by the inhibition of high-affinity cystine uptake, leading to glutathione depletion and accumulation of cellular oxidants. We now demonstrate that primary cultures of rat cortical neurons (E17; 24-72 h in culture), but not glia, also degenerate when exposed to culture medium with reduced cystine or containing competitive inhibitors of cystine uptake, including glutamate. At this developmental stage, neurotoxicity did not occur as a consequence of continuous exposure to glutamate receptor subtype agonists, N-methyl-D-aspartate, kainate, or 2(RS)-amino-3-hydroxy-5-methyl-4-isoxazolepropionate. However, those that inhibited neuronal cystine uptake--quisqualate, glutamate, homocysteate, beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, and ibotenate--were neurotoxic. Toxicity related to quisqualate did not correlate with the development of quisqualate-stimulated phosphatidylinositol turnover. The toxic potencies of glutamate, quisqualate, and homocysteate were inversely proportional to the concentration of cystine in the medium, suggesting that they competitively inhibit cystine uptake. Autoradiographic analysis of the cellular localization of L-[35S]cystine uptake indicated that embryonic neurons have a high-affinity transport system that is sensitive to quisqualate, whereas non-neuronal cells in the same cultures have a low-affinity system that is insensitive to quisqualate but potently blocked by D-aspartate and glutamate. Exposure to glutamate or homocysteate resulted in a time-dependent depletion of the cellular antioxidant glutathione. The centrally acting antioxidant idebenone and alpha-tocopherol completely blocked the neurotoxicity resulting from glutamate exposure. We propose that competitive inhibition of cystine transport and reduction of extracellular cystine levels result in neuronal cell death due to accumulation of cellular oxidants.
Murphy
T H
TH
Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Schnaar
R L
RL
Coyle
J T
JT
D000818:Animals; D016227:Benzoquinones; D001692:Biological Transport / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000187:drug effects*; D003553:Cystine / Q000172:deficiency / Q000378:metabolism*; D005333:Fetus; D005971:Glutamates / Q000633:toxicity*; D006710:Homocysteine / Q000031:analogs & derivatives / Q000633:toxicity; D066298:In Vitro Techniques; D009474:Neurons / Q000502:physiology*; D010069:Oxadiazoles / Q000494:pharmacology; D011809:Quinones / Q000633:toxicity; D016318:Quisqualic Acid; D051381:Rats; D014451:Ubiquinone / Q000031:analogs & derivatives; D014810:Vitamin E / Q000633:toxicity
D016227:Benzoquinones; D005971:Glutamates; D010069:Oxadiazoles; D011809:Quinones; D006710:Homocysteine; C007956:homocysteic acid; D014451:Ubiquinone; D014810:Vitamin E; D003553:Cystine; D016318:Quisqualic Acid; D002217:Carbachol; C036619:idebenone